These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Molecular profiling in the age of cancer genomics. Lin J; Li M Expert Rev Mol Diagn; 2008 May; 8(3):263-76. PubMed ID: 18598106 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in transcription profiling of human cancer. Sültmann H; Poustka A Curr Opin Mol Ther; 2004 Dec; 6(6):593-9. PubMed ID: 15663323 [TBL] [Abstract][Full Text] [Related]
9. Exploring the human genome in cancer with genomic approaches. Scheel JR; Kuo MD J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971 [No Abstract] [Full Text] [Related]
10. Pharmacogenomics: current applications and future prospects towards personalized therapeutics. Vaiopoulou A; Gazouli M; Karikas GA J BUON; 2013; 18(3):570-8. PubMed ID: 24065466 [TBL] [Abstract][Full Text] [Related]
11. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq. Feng H; Qin Z; Zhang X Cancer Lett; 2013 Nov; 340(2):179-91. PubMed ID: 23196057 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer gene expression profiling: clinical trial and practice implications. Loi S; Desmedt C; Cardoso F; Piccart M; Sotiriou C Pharmacogenomics; 2005 Jan; 6(1):49-58. PubMed ID: 15723605 [TBL] [Abstract][Full Text] [Related]
13. Discovering causes and cures for cancer from gene expression analysis. Weeraratna AT Ageing Res Rev; 2005 Nov; 4(4):548-63. PubMed ID: 16243590 [TBL] [Abstract][Full Text] [Related]
17. The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease. Gojis O; Rudraraju B; Alifrangis C; Krell J; Libalova P; Palmieri C Eur J Surg Oncol; 2010 Mar; 36(3):224-9. PubMed ID: 19716257 [TBL] [Abstract][Full Text] [Related]
18. Perspectives and challenges of clinical pharmacogenomics in cancer. Pusztai L Pharmacogenomics; 2004 Jul; 5(5):451-4. PubMed ID: 15212580 [No Abstract] [Full Text] [Related]
19. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium]. Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304 [TBL] [Abstract][Full Text] [Related]
20. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management. Mitra AP; Lin H; Cote RJ; Datar RH Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]